Literature DB >> 1581076

Pulmonary retention of ultrafine and fine particles in rats.

J Ferin1, G Oberdörster, D P Penney.   

Abstract

In aerosol research, particle size has been mainly considered in the context of the role it plays in particle deposition along the respiratory tract. The possibility that the primary particle size may affect the fate of particles after they are deposited was explored in this study. Rats were exposed for 12 wk to aerosolized ultrafine (integral of 21 nm diameter) or fine (integral of 250 nm diameter) titanium dioxide (TiO2) particles. Other rats were exposed to TiO2 particles of various sizes (12, 21, 230, and 250 nm) by intratracheal instillation. After the rat lungs were extensively lavaged, analysis of particle content in the lavaged lungs, lavage fluid, and of lymphatic nodes was performed. Electron and light microscopy was also performed using unlavaged lungs. Both acute instillation and subchronic inhalation studies showed that ultrafine particles (integral of 20 nm) at equivalent masses access the pulmonary interstitium to a larger extent than fine particles (integral of 250 nm). An increasing dose in terms of particle numbers and a decreasing particle size promoted particle access into the interstitium. The translocation of particles into the interstitium appeared to be a function of the number of particles, and the process appeared to be related to the particle size, the delivered dose, and the delivered dose rate. A net effect of the preferential translocation of the smaller particles into the interstitium was a prolongation in their lung retention. After the 12-wk inhalation exposure, pulmonary clearance of ultrafine particles was slower (t1/2 = 501 days) than of larger particles (t1/2 = 174 days).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1581076     DOI: 10.1165/ajrcmb/6.5.535

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  102 in total

Review 1.  Ultrafine particles.

Authors:  K Donaldson; V Stone; A Clouter; L Renwick; W MacNee
Journal:  Occup Environ Med       Date:  2001-03       Impact factor: 4.402

2.  Physical characterization of large porous particles for inhalation.

Authors:  R Gupta; P R Byron
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

3.  Ultrafine particles and nitrogen oxides generated by gas and electric cooking.

Authors:  M Dennekamp; S Howarth; C A Dick; J W Cherrie; K Donaldson; A Seaton
Journal:  Occup Environ Med       Date:  2001-08       Impact factor: 4.402

4.  Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β.

Authors:  Amir S Yazdi; Greta Guarda; Nicolas Riteau; Stefan K Drexler; Aubry Tardivel; Isabelle Couillin; Jürg Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

5.  Pulmonary and cardiovascular responses of rats to inhalation of a commercial antimicrobial spray containing titanium dioxide nanoparticles.

Authors:  W McKinney; M Jackson; T M Sager; J S Reynolds; B T Chen; A Afshari; K Krajnak; S Waugh; C Johnson; R R Mercer; D G Frazer; T A Thomas; V Castranova
Journal:  Inhal Toxicol       Date:  2012-06       Impact factor: 2.724

Review 6.  Stem cells and nanomaterials.

Authors:  Marie-Claude Hofmann
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy.

Authors:  Günter Oberdörster; Andrew Maynard; Ken Donaldson; Vincent Castranova; Julie Fitzpatrick; Kevin Ausman; Janet Carter; Barbara Karn; Wolfgang Kreyling; David Lai; Stephen Olin; Nancy Monteiro-Riviere; David Warheit; Hong Yang
Journal:  Part Fibre Toxicol       Date:  2005-10-06       Impact factor: 9.400

Review 8.  Foreign particles testing in orally inhaled and nasal drug products.

Authors:  James Blanchard; James Coleman; Claire D'Abreu Hayling; Raouf Ghaderi; Barbara Haeberlin; John Hart; Steen Jensen; Richard Malcolmson; Stanley Mittelman; Lee M Nagao; Sonja Sekulic; Caesar Snodgrass-Pilla; Mikael Sundahl; Glenn Thompson; Ronald Wolff
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 9.  Nanoparticles, lung injury, and the role of oxidant stress.

Authors:  Amy K Madl; Laurel E Plummer; Christopher Carosino; Kent E Pinkerton
Journal:  Annu Rev Physiol       Date:  2013-11-06       Impact factor: 19.318

Review 10.  Titanium dioxide nanoparticles: a review of current toxicological data.

Authors:  Hongbo Shi; Ruth Magaye; Vincent Castranova; Jinshun Zhao
Journal:  Part Fibre Toxicol       Date:  2013-04-15       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.